FCBT
SLXP

First Citizens Bank & Trust’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

First Citizens Bank & Trust’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,775
Closed -$386K – 1001
2013
Q3 		$386K Sell
5,775
-7,062
-55% -$487K 0.01% 821
2013
Q2 		$849K Buy
+12,837
New +$734K 0.03% 445

Other funds holding SLXP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

First Citizens Bank & Trust's SLXP Position: Q4 2013 in Review

First Citizens Bank & Trust sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2013, closing a stake of 5,775 shares — an estimated $386K sold.

First Citizens Bank & Trust first reported a position in SLXP in Q2 2013 and held it in 2 quarters. The position peaked at $849K in Q2 2013. 246 funds tracked by Wall St. Rank hold SLXP as of Q4 2013.

  • First Citizens Bank & Trust reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2013 after selling out during the quarter.
  • First Citizens Bank & Trust sold 5,775 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2013, an estimated $386K.
  • First Citizens Bank & Trust first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 2 quarters.
  • First Citizens Bank & Trust's SALIX PHARMACEUTICALS LTD DEL position peaked at $849K in Q2 2013.
  • 246 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2013.

Based on First Citizens Bank & Trust's 13F filing for Q4 2013, filed 13 Feb 2014.